Red Blood Cell Transfusion in Patients With Autoantibodies: Is It Effective and Safe Without Increasing Hemolysis Risk?

BACKGROUND: The therapeutic efficacy of red blood cell (RBC) transfusions in patients with autoimmune hemolytic anemia (AIHA) is highly debated because of speculations on the increased risk of transfusion reactions; yet it is a suggested adjuvant therapy in anemic patients with life-threatening hypo...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Sang Hyuk, Choe, Won-Ho, Kwon, Seog-Woon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Laboratory Medicine 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446583/
https://www.ncbi.nlm.nih.gov/pubmed/26131416
http://dx.doi.org/10.3343/alm.2015.35.4.436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446583/
https://www.ncbi.nlm.nih.gov/pubmed/26131416
http://dx.doi.org/10.3343/alm.2015.35.4.436

Ejemplares similares